The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 28, 2017
Filed:
Apr. 13, 2012
Applicants:
Sophie Chasset, Nandy, FR;
Francis Chevreuil, Chantilly, FR;
Benoit Ledoussal, Pommerit Jaudy, FR;
Frédéric Le Strat, Gagny, FR;
Richard Benarous, Paris, FR;
Inventors:
Sophie Chasset, Nandy, FR;
Francis Chevreuil, Chantilly, FR;
Benoit Ledoussal, Pommerit Jaudy, FR;
Frédéric Le Strat, Gagny, FR;
Richard Benarous, Paris, FR;
Assignee:
LABORATOIRE BIODIM, Paris, FR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 43/16 (2006.01); A61K 31/35 (2006.01); C07D 311/00 (2006.01); C07C 57/38 (2006.01); C07C 59/66 (2006.01); C07D 215/14 (2006.01); C07D 311/58 (2006.01); C07D 405/04 (2006.01); C07D 407/04 (2006.01); A61K 31/192 (2006.01); A61K 31/352 (2006.01); A61K 31/473 (2006.01); C07C 215/14 (2006.01); A61K 31/353 (2006.01); A61K 31/357 (2006.01); A61K 31/47 (2006.01); A61K 31/4709 (2006.01); A61K 31/553 (2006.01); A61K 45/06 (2006.01); C07D 215/54 (2006.01); C07D 311/74 (2006.01); C07D 413/04 (2006.01);
U.S. Cl.
CPC ...
C07C 57/38 (2013.01); A61K 31/192 (2013.01); A61K 31/352 (2013.01); A61K 31/353 (2013.01); A61K 31/357 (2013.01); A61K 31/47 (2013.01); A61K 31/473 (2013.01); A61K 31/4709 (2013.01); A61K 31/553 (2013.01); A61K 45/06 (2013.01); C07C 59/66 (2013.01); C07C 215/14 (2013.01); C07D 215/14 (2013.01); C07D 215/54 (2013.01); C07D 311/58 (2013.01); C07D 311/74 (2013.01); C07D 405/04 (2013.01); C07D 407/04 (2013.01); C07D 413/04 (2013.01);
Abstract
The present invention relates to aromatic carbocycle or heterocycle compounds comprising an acid function and being of formula (5), wherein W, Q, Q, Q, Q, R, R, R, R, R, R, a, c, e, and g are as described in the description; and the use of such compounds in the treatment or the prevention of viral disorders, including HIV.